Fairmount Funds Sells 3.5 Million Cogent Shares in Strategic Trim Ahead of New Biotech Pipeline
Fairmount sells 3.5 M Cogent Biosciences shares at $36.40, a near‑market tactical move that may reshape investor strategy and signals potential upside.
3 minutes to read